10
Participants
Start Date
May 5, 2015
Primary Completion Date
March 31, 2021
Study Completion Date
March 31, 2021
Carfilzomib
"Given IV; Dose Level (DL)~Twice Weekly:~DL -1 and DL 1: 15 mg/m\^2~Weekly:~DL 1.5: 20,27,27 mg/m\^2, DL 2: 20,36,36 mg/m\^2, DL 3: 20,56,56 mg/m\^2 DL 4: 20,70,70 mg/m\^2"
Bendamustine
"Given IV; Dose Level (DL)~DL -1: 75 mg/m\^2 DL 1,1.5, 2, 3, and 4: 90 mg/m\^2"
Rituximab
Given IV; 375 mg/m\^2
University of California, San Diego, San Diego
University of California, San Francisco, San Francisco
University of California, Davis, Davis
National Comprehensive Cancer Network
NETWORK
University of California, San Francisco
OTHER